Skip to main content
. 2021 Feb;22(2):565–571. doi: 10.31557/APJCP.2021.22.2.565

Table 3.

Genetic Association of FAS-670 A>G and FASL -844 T>C Polymorphisms with IM Response in CML Patient

FAS -670 A>G Treatment status (n=93)
Resistance (n=46) Response (n=47) P value Adjusted OR (95% CI) P value
Genotype
AA 8 (17.4%) 5 (10.6%) 0.348 1 (Reference)
AG 22 (47.8%) 32 (68.1%) 0.048* 0.429 (0.124-1.488) 0.43
GG 16 (34.8%) 10 (21.3%) 0.147 1.000 (0.255-3.929) 1
Allele
A 38 (41.3%) 42 (44.7%) 1 (Reference)
G 54 (58.7%) 52 (55.3%) 0.639 1.148 (0.642-2.052) 0.639
FASL-844 T>C Treatment status (n=90)
Resistance (n=45) Response (n=45) P value Adjusted OR (95% CI) P value
Genotype
TT 17 (37.8%) 5 (11.1%) 0.003* 1 (Reference) -
TC 7 (15.5%) 16 (35.6%) 0.029* 0.129 (0.034-0.489) 0.003*
CC 21 (46.7%) 24 (53.3%) 0.527 0.257 (0.081-0.818) 0.021*
Allele
T 41 (45.6%) 26 (28.9%) 1 (Reference)
C 49 (54.4%) 64 (71.1%) 0.002* 0.486 (0.262-0.899) 0.021*

*p<0.05 statistically significant; OR, odd ratio; CI, confidence interval